According to the US Health announcement, revenue for the first three quarters of 2026 is expected to be 6.51 billion yuan to 6.65 billion yuan, down 3.98% — 6.00% year on year; net profit to mother of 91 million yuan to 100 million yuan, an increase of 75.47% — 92.83% over the same period last year; profit after deducting non-net profit of 80 million yuan to 89 million yuan, an increase of 554.19% — 627.78% over the same period last year. The financial data related to this performance forecast has not been audited by a certified public accountant.

According to the US Health announcement, revenue for the first three quarters of 2026 is expected to be 6.51 billion yuan to 6.65 billion yuan, down 3.98% — 6.00% year on year; net profit to mother of 91 million yuan to 100 million yuan, an increase of 75.47% — 92.83% over the same period last year; profit after deducting non-net profit of 80 million yuan to 89 million yuan, an increase of 554.19% — 627.78% over the same period last year. The financial data related to this performance forecast has not been audited by a certified public accountant.